Sofia Ioannidou
Director/Board Member at Avalyn Pharma, Inc.
Profile
Sofia Ioannidou - Partner
Sofia Ioannidou joined Andera Partners’ Andera Life Sciences team in 2009 as an Associate.
She was promoted to Partner in 2019.
Prior to Andera Partners, Sofia was part of the Life Sciences team of L.E.K.
Consulting London, from 2006 to 2008, having started her career in R&D with Boston-based Eyetech Pharmaceuticals, Inc., from 2003 to 2006.
Since 2009, she has actively contributed to a number of investments, trade sales and IPOs.
Sofia currently serves on the board of Tubulis, Tricares, Avalyn, and Exciva and has previously served on the boards of LogicBio, Sanifit and PegaOne.
She holds a PhD in Cell Biology from Cancer Research UK and an MBiochem from the University of Oxford.
Sofia is a native Greek speaker and also speaks English, French and Spanish.
Sofia Ioannidou active positions
| Companies | Position | Start |
|---|---|---|
Andera Partners SCA
 Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Private Equity Investor | 2013-02-28 |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Director/Board Member | - |
Former positions of Sofia Ioannidou
| Companies | Position | End |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Director/Board Member | 2019-06-24 |
TRiCares SAS
 TRiCares SAS Medical SpecialtiesHealth Technology Tricares SAS commercializes medical device. The company was founded by Coralie Marchand and Pascal Lim on September 2, 2013 and is headquartered in Paris, France. | Director/Board Member | - |
| CELLNOVO | Director/Board Member | - |
Training of Sofia Ioannidou
| University of Oxford | Graduate Degree |
| University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Andera Partners SCA
Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Finance |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
TRiCares SAS
TRiCares SAS Medical SpecialtiesHealth Technology Tricares SAS commercializes medical device. The company was founded by Coralie Marchand and Pascal Lim on September 2, 2013 and is headquartered in Paris, France. | Health Technology |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Sofia Ioannidou
